In addition, it was reported that an anti-inflammatory cytokine TNFα-stimulating gene 6 (TSG-6) released from intraperitoneally injected MSCs play a role to improve IBD through polarization macrophages toward M2 phenotype [33]. The gene discussed is TNFAIP6; the disease is inflammatory bowel disease.